LOAMU
XBI icon

Lombard Odier Asset Management (USA)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,000
Closed -$330K – 247
2016
Q3 		$330K Buy
+5,000
New +$309K 0.03% 232

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s XBI Position: Q4 2016 in Review

Lombard Odier Asset Management (USA) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2016, closing a stake of 5,000 shares — an estimated $330K sold.

Lombard Odier Asset Management (USA) first reported a position in XBI in Q3 2016 and held it in 1 quarter. The position peaked at $330K in Q3 2016. 274 funds tracked by Wall St. Rank hold XBI as of Q4 2016.

  • Lombard Odier Asset Management (USA) reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2016 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 5,000 State Street SPDR S&P Biotech ETF shares in Q4 2016, an estimated $330K.
  • Lombard Odier Asset Management (USA) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s State Street SPDR S&P Biotech ETF position peaked at $330K in Q3 2016.
  • 274 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2016, filed 15 Feb 2017.